Company Search:
Advanced Search
Sponsored Links
Reneuron Group PLC Company Snapshot
Reneuron Group PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Reneuron Group PLC with three other miscellaneous service companies in Europe: E-Therapeutics Plc (2019 sales of £44,000.00 [US$57,818.64 ] of which 100% was Drug Discovery & Development), Biovica International AB of Sweden (3.01 million Swedish Kronor [US$315,194.45 ] ), and Diamyd Medical Ab which is also based in Sweden (1.57 million Swedish Kronor [US$164,467.52 ] ).

Sales Analysis. Reneuron Group PLC reported sales of £49,000.00 (US$64.39 thousand) for the fiscal year ending March of 2019. This represents an increase of 14.0% versus 2018, when the company's sales were £43,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Reneuron Group PLC
  Stock Performance Chart for Reneuron Group PLC
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 141.00p
(Figures in Pounds Sterling)
1 Week 3.7%   13 Weeks 10.6%  
4 Weeks -29.7%   52 Weeks 163.6%  
Reneuron Group PLC Key Data:
  Ticker: RENE Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 49,000
(Year Ending Jan 2020).
Employees: 59
  Currency: Pounds Sterling Market Cap: 44,883,501
  Fiscal Yr Ends: March Shares Outstanding: 31,832,270
  Share Type: Ordinary Closely Held Shares: 1,298,123
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.